Furthermore, high CML-AGE accretion was substantially related to adverse prognosis and chemotherapy outcome in patients with estrogen-receptor negative (triple receptor negative and grade III carcinoma) breast cancer [22]. The gene discussed is ESR1; the disease is breast carcinoma.